Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Nitric Oxide ; 149: 75-84, 2024 Jun 13.
Article in English | MEDLINE | ID: mdl-38879114

ABSTRACT

Obesity is commonly linked with white adipose tissue (WAT) dysfunction, setting off inflammation and oxidative stress, both key contributors to the cardiometabolic complications associated with obesity. To improve metabolic and cardiovascular health, countering these inflammatory and oxidative signaling processes is crucial. Offering potential in this context, the activation of nuclear factor erythroid 2-related factor 2 (Nrf2) by nitro-fatty acids (NO2-FA) promote diverse anti-inflammatory signaling and counteract oxidative stress. Additionally, we previously highlighted that nitro-oleic acid (NO2-OA) preferentially accumulates in WAT and provides protection against already established high fat diet (HFD)-mediated impaired glucose tolerance. The precise mechanism accounting for these protective effects remained largely unexplored until now. Herein, we reveal that protective effects of improved glucose tolerance by NO2-OA is absent when Nrf2 is specifically ablated in adipocytes (ANKO mice). NO2-OA treatment did not alter body weight between ANKO and littermate controls (Nrf2fl/fl) mice on both the HFD and low-fat diet (LFD). As expected, at day 76 (before NO2-OA treatment) and notably at day 125 (daily treatment of 15 mg/kg NO2-OA for 48 days), both HFD-fed Nrf2fl/fl and ANKO mice exhibited increased fat mass and reduced lean mass compared to LFD controls. However, throughout the NO2-OA treatment, no distinction was observed between Nrf2fl/fl and ANKO in the HFD-fed mice as well as in the Nrf2fl/fl mice fed a LFD. Glucose tolerance tests revealed impaired glucose tolerance in HFD-fed Nrf2fl/fl and ANKO compared to LFD-fed Nrf2fl/fl mice. Notably, NO2-OA treatment improved glucose tolerance in HFD-fed Nrf2fl/fl but did not yield the same improvement in ANKO mice at days 15, 30, and 55 of treatment. Unraveling the pathways linked to NO2-OA's protective effects in obesity-mediated impairment in glucose tolerance is pivotal within the realm of precision medicine, crucially propelling future applications and refining novel drug-based strategies.

2.
Ultrasound Obstet Gynecol ; 51(5): 659-664, 2018 May.
Article in English | MEDLINE | ID: mdl-28436133

ABSTRACT

OBJECTIVES: Dextro-transposition of the great arteries (d-TGA) is one of the most common critical neonatal heart defects, with a low detection rate antenatally. We sought to evaluate trends in the prenatal detection of d-TGA with or without ventricular septal defect (VSD) in Alberta over the past 13 years, examining the potential impact of ultrasound guidelines incorporating screening of cardiac outflow tracts, updated in 2009-2010 and in 2013, and factors affecting detection of the condition. METHODS: All fetuses and neonates with d-TGA, with or without VSD, encountered between 2003 and 2015 in the province of Alberta, were identified retrospectively. Clinical records including obstetric ultrasound reports were reviewed. Pregnancy outcome, common referral indications and associated maternal and fetal pathology in affected pregnancies were assessed. RESULTS: From 2003 to 2015, 127 cases with d-TGA were encountered in Alberta, of which 47 (37%) were detected prenatally. Prenatal detection improved over the study period, from 14% in 2003-2010, to 50% in 2011-2013, and to 77% in 2014-2015. Of the 47 fetuses with a prenatal diagnosis of d-TGA, an indication for fetal echocardiography included abnormal or poorly visualized cardiac outflows with normal four-chamber view in 46 (98%). Comorbidities were identified in 12 mothers, only five of which represented an additional reason for fetal echocardiography referral, and four fetuses had extracardiac pathology. CONCLUSION: Substantial improvement in the prenatal detection of d-TGA has been observed in Alberta over the past few years, owing to improved screening of cardiac outflow tracts on routine obstetric ultrasound examination in otherwise healthy pregnancies, and has been temporally associated with updated obstetric ultrasound guidelines suggesting that these contributed to optimized screening of affected pregnancies. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Transposition of Great Vessels/diagnosis , Ultrasonography, Prenatal/standards , Alberta/epidemiology , Echocardiography , Female , Gestational Age , Humans , Practice Guidelines as Topic , Pregnancy , Referral and Consultation/statistics & numerical data , Transposition of Great Vessels/classification , Transposition of Great Vessels/epidemiology
4.
Ultrasound Obstet Gynecol ; 42(3): 294-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23456797

ABSTRACT

OBJECTIVE: Decreased middle cerebral artery (MCA) pulsatility index (PI) is a marker of fetal brain-sparing in placental insufficiency and it is also found in fetuses with severe congenital heart disease. This study sought to explore the impact of anatomical subtypes in fetal heart disease on MCA-PI and head growth. METHODS: We retrospectively reviewed fetal echocardiograms of pregnancies complicated by fetal hypoplastic left heart syndrome (HLHS; n = 42) with and without anatomic coarctation (n = 28 and n = 10, respectively), isolated severe aortic coarctation (n = 21), D-transposition of the great arteries (TGA; n = 11) and pulmonary outflow tract obstruction without forward flow across the pulmonary valve (POTO; n = 15), comparing observations with gestational age-matched controls (n = 89). No fetus had major extracardiac pathology or aneuploidy. MCA and umbilical artery (UA) PI, the cerebral placental ratio (CPR = MCA-PI/ UA-PI) and neonatal head circumference were obtained and expressed as Z-scores. RESULTS: Lower MCA-PI, higher UA-PI and lower CPR were observed in fetal HLHS and isolated coarctation with reversed arch flow (n = 6) (P < 0.001) but not TGA, POTO or isolated coarctation with antegrade arch flow (n = 15) compared with controls. No difference was found between HLHS with anatomical coarctation and those without; however, MCA-PI correlated positively with neonatal head circumference in HLHS with reversed distal arch flow (r = 0.33, P < 0.05). CONCLUSIONS: Severe left heart obstruction with reversed aortic arch flow is associated with altered fetal cerebral blood flow, and in these conditions, MCA-PI positively correlates with head growth. Anatomical arch obstruction itself may not be a contributing factor to altered MCA flow in fetal HLHS.


Subject(s)
Fetal Development/physiology , Fetal Diseases/pathology , Head/physiopathology , Middle Cerebral Artery/physiopathology , Pulsatile Flow/physiology , Aorta, Thoracic/pathology , Aortic Coarctation/diagnostic imaging , Aortic Coarctation/pathology , Cerebrovascular Circulation/physiology , Echocardiography , Female , Fetal Diseases/diagnostic imaging , Fetal Hypoxia/physiopathology , Humans , Hypoplastic Left Heart Syndrome/diagnostic imaging , Hypoplastic Left Heart Syndrome/pathology , Infant, Newborn , Middle Cerebral Artery/diagnostic imaging , Placental Circulation/physiology , Pregnancy , Retrospective Studies , Transposition of Great Vessels/diagnostic imaging , Transposition of Great Vessels/pathology
5.
Lasers Med Sci ; 28(6): 1527-32, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23358875

ABSTRACT

Intravenous laser blood irradiation (ILBI) is widely applied in the treatment of different pathologies including diabetes mellitus. The aim of this study is to evaluate the effects of ILBI on the metabolites of blood in diabetic type 2 patients using metabolomics. We compared blood samples of nine diabetic type 2 patients, using metabolomics, before and after ILBI with blue light laser. The results showed significant decrease in glucose, glucose 6 phosphate, dehydroascorbic acid, R-3-hydroxybutyric acid, L-histidine, and L-alanine and significant increase in L-arginine level in blood and blood sugar in the patients have reduced significantly (p < 0.05). This study clearly demonstrated a significant positive effect of ILBI on metabolites of blood in diabetic type 2 patients. These findings support the therapeutic potential of ILBI in diabetic patients.


Subject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/radiotherapy , Low-Level Light Therapy/methods , Metabolome/radiation effects , 3-Hydroxybutyric Acid/blood , Amino Acids/blood , Blood Glucose/radiation effects , Dehydroascorbic Acid/blood , Endovascular Procedures , Female , Glucose-6-Phosphate/blood , Humans , Least-Squares Analysis , Magnetic Resonance Spectroscopy , Male , Middle Aged
6.
Free Radic Biol Med ; 28(7): 1143-56, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10832077

ABSTRACT

We hypothesized that the cytotoxic effect of GLA observed in glioma but not normal glial cells reflects differences in GLA metabolism and/or antioxidant enzyme levels between these cells. The PUFA content of unsupplemented glioma cells was approximately 50% of that seen in unsupplemented astrocytes. Supplementation with 20 microM GLA for 24 h led to a 230 and 22% increase in glioma and astrocyte PUFA content, respectively, such that both supplemented cell types contained similar levels of PUFA. No major differences were seen in terms of GLA metabolites retained in the cells or secreted into the media following incubation with [(3)H]-GLA. No significant differences were observed in activity of MnSOD or CuZn-SOD between the cells. However, CAT and GPx activity in the glioma cells was significantly higher and lower, respectively, than observed in normal astrocytes. GLA supplementation resulted in a significant increase in CAT activity in normal astrocytes; glioma CAT activity was unchanged. No significant change was seen in the other antioxidant enzymes following GLA supplementation. These results suggest that the cytotoxic effect of GLA on glioma cells reflects both increased PUFA content and an inability to upregulate CAT.


Subject(s)
Antioxidants/metabolism , Glioma/enzymology , gamma-Linolenic Acid/toxicity , Animals , Astrocytes/metabolism , Carbon Radioisotopes/metabolism , Catalase/biosynthesis , Catalase/metabolism , Catalase/physiology , Culture Media, Conditioned , Fatty Acids, Unsaturated/analysis , Glioma/metabolism , Glutathione Reductase/biosynthesis , Glutathione Reductase/metabolism , Glutathione Reductase/physiology , Lipid Metabolism , Rats , Superoxide Dismutase/biosynthesis , Superoxide Dismutase/metabolism , Superoxide Dismutase/physiology , Tumor Cells, Cultured , gamma-Linolenic Acid/metabolism
7.
Int Immunol ; 12(2): 215-22, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10653857

ABSTRACT

Ly49 receptors are inhibitory receptors expressed on subsets of both NK cells and NK1.1(+) T cells. The function of these receptors on NK cells is believed to be important in maintaining self-tolerance, yet their role on T cells is unclear. In this report we investigated how an Ly49A transgene alters T and NK cell development in an in vivo environment, where a ligand for Ly49A is expressed. Ly49A transgenic mice that co-expressed an MHC ligand for Ly49A, H-2D(d), developed a severe inflammatory disorder that resulted in death within the first weeks of age. T cells expressing forbidden TCR V(beta) chains were found both in the thymus and periphery of transgenic mice, while non-transgenic littermates had successfully deleted these T cell subsets. These data indicate that the expression of Ly49A on T cells could alter T cell selection and allow survival of potentially self-reactive T cells.


Subject(s)
Antigens, Ly , Killer Cells, Natural/immunology , Receptors, Immunologic/physiology , T-Lymphocytes/immunology , Animals , H-2 Antigens/immunology , H-2 Antigens/metabolism , Histocompatibility Antigen H-2D , Inflammation/immunology , Inflammation/pathology , Lectins, C-Type , Liver/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Myocardium/pathology , NK Cell Lectin-Like Receptor Subfamily A , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Receptors, Immunologic/genetics , Receptors, NK Cell Lectin-Like , T-Lymphocytes/metabolism , Thymus Gland/cytology , Transgenes
8.
Immunology ; 95(1): 126-31, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9767467

ABSTRACT

The expression of murine Ly49 receptors on natural killer (NK) cells and NK1.1+ T cells is believed to prevent these cells from responding against normal self-tissues. In this report we investigated whether the expression level of Ly49A was fixed on mature cells or if it could be adapted as the major histocompatibility complex (MHC) class I environment changed in vivo. By transferring peripheral T cells from Ly49A transgenic mice into BALB/c nude/nude and B6 nude/nude mice, we demonstrated that mature cells modulate their Ly49A receptor expression relative to the in vivo MHC class I environment. These results indicated that the expression of the inhibitory Ly49A receptor is not permanently fixed during a maturation and/or education process but rather is adapted to MHC class I changes on the surrounding cells.


Subject(s)
Antigens, Ly , Histocompatibility Antigens Class I , Killer Cells, Natural/immunology , Membrane Glycoproteins/immunology , Receptors, Immunologic/immunology , Animals , Flow Cytometry , Hematopoietic Stem Cell Transplantation , Killer Cells, Natural/transplantation , Lectins, C-Type , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Nude , Mice, Transgenic , NK Cell Lectin-Like Receptor Subfamily A , Receptors, NK Cell Lectin-Like
9.
Int J Cancer ; 77(3): 429-39, 1998 Jul 29.
Article in English | MEDLINE | ID: mdl-9663607

ABSTRACT

Invasion of the uterus by first trimester human placental extravillous trophoblast (EVT) cells depends on mechanisms shared by malignant cells. However, unlike tumor invasion, trophoblast invasion of the uterus is stringently controlled in situ by local molecules such as transforming growth factor (TGF)beta. Since EVT cells possess active invasion-associated genes but are nontumorigenic, our objective was to induce premalignant and then malignant phenotype into a normal EVT cell line in order to identify the molecular basis of tumor progression. Simian virus 40 large T antigen (SV40 Tag) was introduced into a normal human first trimester invasive EVT cell line, HTR8, established in our laboratory. Since the HTR8 line has a limited in vitro lifespan of 12-15 passages, SV40 Tag-transformed cells were selected on the basis of extended lifespan. A long-lived line, RSVT-2, was produced and an immortalized subclone, RSVT2/C, was further derived under a forced crisis regimen. We examined transformation-induced alterations in proliferative and invasive abilities, responses to the invasion and proliferation-regulating growth factor TGFbeta and changes in gene expression for invasion-associated enzymes or enzyme inhibitors. RSVT-2 and RSVT2/C cell lines were hyperproliferative and hyperinvasive when compared with the parental HTR8 cell line. They were also variably resistant to the anti-proliferative and anti-invasive signals from TGFbeta. Since both cell lines remained non-tumorigenic in nude mice, these properties indicate that they attained a premalignant phenotype. Both cell lines showed reduced expression of tissue inhibitor of metalloproteases (TIMP)-1, while TIMP-2 and plasminogen activator inhibitor (PAI)-I expression was was also reduced in RSVT2/C cells, thus contributing to their hyperinvasiveness. Their resistance to the anti-invasive action of TGFbeta was explained by the failure of TGFbeta to upregulate TIMPs and PAI-I, in contrast to the TGFbeta-induced upregulation noted in parental HTR8 cells.


Subject(s)
Cell Transformation, Neoplastic , Neoplasm Invasiveness/pathology , Precancerous Conditions/pathology , Transforming Growth Factor beta/pharmacology , Trophoblasts/pathology , Animals , Antigens, Viral, Tumor/biosynthesis , Antigens, Viral, Tumor/genetics , Cell Division , Cell Line , Choriocarcinoma/pathology , Clone Cells , Drug Resistance, Neoplasm , Female , Gene Expression Regulation, Neoplastic , Humans , Mice , Mice, Nude , Neoplasm Invasiveness/prevention & control , Phenotype , Plasminogen Activator Inhibitor 1/biosynthesis , Pregnancy , Pregnancy Trimester, First , Simian virus 40/genetics , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Tissue Inhibitor of Metalloproteinase-2/biosynthesis , Transplantation, Heterologous , Trophoblasts/cytology , Tumor Cells, Cultured
10.
Int J Cancer ; 77(3): 440-8, 1998 Jul 29.
Article in English | MEDLINE | ID: mdl-9663608

ABSTRACT

Poor gap junctional intercellular communication (GJIC) has been associated with uncontrolled cell growth and neoplasia. We have successfully propagated normal first trimester invasive extravillous trophoblast (EVT) cells, and have produced premalignant EVT lines after SV40 Tag transformation: RSVT-2 is an uncloned line that is long-lived; RSVT2/C is a clonal line that is immortal. Both are hyperproliferative, hyperinvasive and variably refractory to the anti-proliferative and anti-invasive effects of transforming growth factor beta (TGFbeta). Possible changes in gap junctions during the transition of normal invasive EVT cells to the premalignant stage were examined by comparing expression of connexin proteins (by immunolabeling for Cx26, Cx32, Cx40, Cx43), and mRNA (by Northern blot with cDNA probes for Cx26, Cx32, Cx43), and functional GJIC (by dye transfer using the preloading method) in normal parental EVT cells and their SV40 Tag transformants. Results from immunofluorescence and Northern blot analysis revealed that, of the panel of connexins examined, only Cx43 was variably expressed in these cell lines in vitro. Expression of Cx43 protein and mRNA was abundant in normal EVT cell line HTR8, reduced in long-lived RSVT-2 cells and undetectable in immortalized RSVT2/C cells. GJIC, as measured by dye transfer between donor and recipient cells, was also similarly reduced in recipient RSVT-2 cells, and drastically reduced in RSVT2/C cells, irrespective of whether the dye donor was of the same cell type (homocellular coupling) or HTR8 cells (heterocellular coupling). Treatment with TGFbeta reduced Cx43 mRNA expression as well as GJIC in normal EVT cells, but not in the SV40 Tag transformants. Our findings suggest that downregulation of connexins with the resultant impairment in GJIC is an early event in tumor progression, as observed in the premalignant SV40 Tag transformants.


Subject(s)
Cell Communication/physiology , Cell Transformation, Neoplastic , Gap Junctions/physiology , Neoplasm Invasiveness/pathology , Precancerous Conditions/pathology , Trophoblasts/pathology , Analysis of Variance , Antigens, Viral, Tumor/biosynthesis , Antigens, Viral, Tumor/genetics , Connexin 26 , Connexin 43/analysis , Connexin 43/biosynthesis , Connexins/analysis , Connexins/biosynthesis , Female , Gap Junctions/pathology , Gene Expression Regulation, Neoplastic , Humans , Phenotype , Pregnancy , Pregnancy Trimester, First , RNA, Messenger/biosynthesis , Simian virus 40/genetics , Transcription, Genetic , Trophoblasts/cytology
11.
Eur J Immunol ; 27(8): 2057-65, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9295045

ABSTRACT

Inhibitory receptors expressed on natural killer (NK) cells and T cells specific for major histocompatibility complex (MHC) class I are believed to prevent these cells from responding to normal self tissues. To understand the regulation and function of Ly49 receptor molecules in vivo, we used the CD2 promoter to target Ly49A expression to all thymocytes, T cells, and NK cells. In animals expressing its MHC class I ligand, H-2Dd or H-2Dk, there was a large decrease in the expression of Ly49A on thymocytes, peripheral T cells, and NK1.1+ cells. The extent of the down-regulation of Ly49A was dependent on the expression of the MHC ligand for Ly49A and on the site where the cells were located. The level of expression of endogenous Ly49A was similarly found to be dependent upon the organ where the cells resided. Data from bone marrow chimeras indicated that most cell types may regulate Ly49A expression, but the efficacy to regulate receptor expression may vary depending on the cell type.


Subject(s)
Antigens, Ly , H-2 Antigens/metabolism , Membrane Glycoproteins/immunology , Receptors, Immunologic/metabolism , Animals , Cells, Cultured , Concanavalin A/pharmacology , Down-Regulation , Female , Gene Expression , H-2 Antigens/genetics , Hematopoietic System/cytology , Hematopoietic System/immunology , Hematopoietic System/metabolism , Histocompatibility Antigen H-2D , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Lectins, C-Type , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , NK Cell Lectin-Like Receptor Subfamily A , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Immunologic/genetics , Receptors, NK Cell Lectin-Like , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Thymus Gland/cytology , Thymus Gland/immunology , Thymus Gland/metabolism , Tissue Distribution
12.
Am J Ind Med ; 31(2): 148-52, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9028430

ABSTRACT

The objectives of this study were to determine the exposure levels among workers who handle 2-ethoxyethylacetate (EGEEA) in the liquid crystal display (LCD) manufacturing industry and to study the menstrual patterns among the exposed workers compared to a referent group of workers. A total of 52 female exposed workers and 55 referents was studied. Detailed menstrual histories were obtained by personal interview using a structured questionnaire. All the exposed had individual 8-hour personal monitoring for EGEEA in the environment and start-of-shift and end-of-shift urine analysis for EGEEA concentration. The geometric mean end-of-shift urine EGEEA concentration was 0.16 mg/g creatinine. End-of-shift urine EGEEA was well correlated with the air concentration; r = 0.81 [p < 0.0001]. No significant differences were observed between the exposed and referent groups for duration of each menstrual cycle (period), duration (days) of the menses, and the amount of flow, even after adjusting for possible confounders viz. age, years of education, use of oral contraceptive pills, age at menarche, gravidity, and race. The workers in the LCD manufacturing industry were exposed to a mean TWA of 0.51 ppm of EGEEA. At this concentration, the findings did not reveal any significant difference between the menstrual patterns of the exposed and referent subjects.


Subject(s)
Ethylene Glycols/adverse effects , Menstruation/drug effects , Occupational Exposure , Adult , Air Pollutants, Occupational/analysis , Confounding Factors, Epidemiologic , Ethylene Glycols/analysis , Ethylene Glycols/urine , Female , Humans , Industry , Surveys and Questionnaires
13.
Cell Growth Differ ; 7(10): 1403-13, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8891344

ABSTRACT

Transfection of C6 glioma cells with connexin43 (Cx43) cDNA under a constitutive promoter resulted in expression of Cx43 protein, an increase in functional gap junctions, and reduced growth under in vitro and in vivo conditions (D. Zhu et al., Proc. Natl. Acad. Sci. USA, 88: 1883-1887, 1991). To allow for precise temporal and quantitative control of Cx43 gene expression, the Cx43 cDNA was inserted into an expression vector [pSV2M(2)6] containing a modified metallothionein promoter. Upon transfection of this vector into C6 cells, clones were isolated that expressed increased levels of inducible Cx43 protein and dye coupling. The level of induction of Cx43 expression increased with increasing concentration of Zn2+, thus enabling the use of the same clone with different levels of gap junctions present. Although we observed no change in cell growth under in vitro conditions following exposure to Zn2+ or Cd2+, clones with inducible expression of Cx43 were characterized by reduced growth in vivo. Within tumors, the level of expression of Cx43 mRNA and protein corresponded to that seen in vitro following the addition of Zn2+. The suppression of tumor growth in vivo correlated with the level of induced Cx43 expression.


Subject(s)
Connexin 43/genetics , Gene Expression Regulation , Metallothionein/genetics , Promoter Regions, Genetic/genetics , Animals , Connexin 43/biosynthesis , Gene Transfer Techniques , Rats , Tumor Cells, Cultured
15.
Cell Growth Differ ; 5(2): 179-86, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8180131

ABSTRACT

C6 glioma cells do not express the gap junction protein connexin32 or its corresponding mRNA. Very low levels of connexin43 protein and mRNA, as well as weak intercellular coupling, have been detected. Studies investigating the role of gap junctions in cell proliferation and tumorigenesis have shown that C6 cells transfected with connexin43 have increased levels of intercellular coupling and reduced cell growth (D. Zhu et al., Proc. Natl. Acad. Sci. USA, 88:1883-1887, 1991). To determine whether this growth inhibition is observed with other connexins, a full-length cDNA for connexin32 was used to transfect C6 cells. A number of transfected clones, expressing various levels of connexin32 mRNA, were obtained. Further analysis of several of these clones has shown that they have a corresponding increase in both the amount of connexin32 immunoreactivity and intercellular coupling. Thus, transfection of the C6 glioma cell line with connexin32, a gene which is normally expressed in the rat brain but not in C6 cells, produces both a functional mRNA and protein. Growth of the transfected clones was reduced in vivo. In vitro, growth of the various clones was not correlated to either levels of connexin32 expression or intercellular coupling. This is in contrast to findings in the previous study, in which cell growth was reduced in response to connexin43 expression both in vivo and in vitro in the transfected cells. These clones provide a unique system to study the role of gap junctions in cell proliferation and other tumor characteristics.


Subject(s)
Brain/metabolism , Cell Division , Connexins/biosynthesis , Glioma/pathology , RNA, Messenger/biosynthesis , Animals , Blotting, Northern , Cell Line , Connexin 43/biosynthesis , DNA, Complementary/metabolism , Glioma/metabolism , Kinetics , Mice , Mice, Nude , RNA, Messenger/analysis , Rats , Transfection , Transplantation, Heterologous , Tumor Cells, Cultured , Gap Junction beta-1 Protein
17.
Exp Cell Res ; 206(2): 204-11, 1993 Jun.
Article in English | MEDLINE | ID: mdl-7684692

ABSTRACT

We established trophoblast cell cultures with extended lifespans by introducing into first trimester human trophoblasts the gene encoding simian virus 40 large T antigen. The transfected trophoblasts were characterized according to their expression of various morphological and functional markers. Both parental (HTR-8) and transfected (HTR-8/SVneo) lines were morphologically similar and positive for cytokeratin, confirming their epithelial (trophoblastic) identity. Whereas the parental cells senesced after 12-14 passages, the transfectants have been in culture for over 32 passages. Human chorionic gonadotrophin was detected only in the HTR-8/SVneo cells and not in the parental cells. Both lines required at least 5% serum in order to sustain growth in vitro and responded to transforming growth factor-beta (TGF-beta) with reduced [3H]-thymidine incorporation in a dose-dependent manner. Treatment with TGF-beta also resulted in decreased secretion of plasminogen activators (PAs) and reduced PA activity by both lines. Both cell lines secreted mostly 72-kDa type IV collagenase as determined by substrate gel zymography, but the level of secretion of this enzyme was not significantly affected by TGF-beta in either line. Even though both lines exhibited similar in vitro invasive abilities, only the invasiveness of the parental cells was reduced by TGF-beta. Neither parental or transfected cells were capable of growth in soft agar and no sign of tumor formation was evident more than 5 months after subcutaneous inoculation of the transfected cells into nude mice. These results indicate that apart from their ability to sustain prolonged growth in culture, the transfected HTR-8/SVneo cells share a number of phenotypic properties with the parental trophoblast cells. For this reason, these transfected trophoblasts may prove to be an important tool for the study of placental function and/or tumor progression.


Subject(s)
Trophoblasts/cytology , Animals , Cell Division , Chorionic Gonadotropin/metabolism , Culture Media , Culture Techniques/methods , DNA Replication , Endopeptidases/analysis , Endopeptidases/metabolism , Female , Gelatinases , Humans , Keratins/metabolism , Kinetics , Mice , Mice, Nude , Pregnancy , Pregnancy Trimester, First , Simian virus 40/genetics , Thymidine/metabolism , Transfection/methods , Transforming Growth Factor beta/pharmacology , Transplantation, Heterologous , Trophoblasts/drug effects , Trophoblasts/metabolism
18.
Clin Exp Metastasis ; 11(3): 275-83, 1993 May.
Article in English | MEDLINE | ID: mdl-8097142

ABSTRACT

Histamine type-2 receptor antagonists (H-2RA) have been used chronically to prevent dyspepsia in cancer patients subjected to immunotherapy with chronic indomethacin (Indo) and intermittent IL-2 in our cancer centre. We tested the effects of these agents during immunotherapy of C3H/HeJ mice transplanted s.c. with 5 x 10(5) C3L5 mammary adenocarcinoma cells. Tumor-transplanted mice were divided into groups receiving: (1) Indo (14 micrograms/ml); (2) H-2RA, i.e. (a) ranitidine at 28.6 micrograms/ml (Ran-lo) or 143 micrograms/ml (Ran-hi), or (b) famotidine (Fam) at 4.3 micrograms/ml, or (c) cimetidine (Cim) at 107 micrograms/ml, all in the drinking water on days 5-24; (3) IL-2 (1.5 x 10(3) Cetus U i.p. every 8 h on days 10-14 and 20-24); (4) combinations of H-2RA + Indo; or (5) combinations of H-2RA + Indo + IL-2. Animals were killed on day 24 for examination of primary s.c. tumor growth, secondary lung metastasis and splenocyte cytotoxicity against YAC-1 lymphoma cells (51Cr release assay). Results revealed: (1) primary tumor growth was reduced in mice treated with Fam + Indo, Indo + IL-2 and any of the H-2RA + Indo + IL-2 (no difference observed within the last two groups); (2) lung metastases decreased in mice treated with IL-2 alone, Indo + IL-2, and Indo + IL-2 + Ran-hi; (3) splenic cytotoxicity was suppressed in tumor-bearing controls, with partial restoration seen in Ran (both doses), Ran-lo + Indo, Ran-lo + Indo + IL-2, and Cim + Indo + IL-2 treated groups. Nearly complete restoration was seen in Cim, Cim + Indo, Indo + IL-2, Ran-hi + Indo + IL-2, and Fam + Indo + IL-2 groups. Thus, addition of H-2RA did not alter the overall therapeutic efficacy of the standard Indo + IL-2 tumor immunotherapy.


Subject(s)
Adenocarcinoma/secondary , Histamine H2 Antagonists/therapeutic use , Immunotherapy, Adoptive , Indomethacin/therapeutic use , Lung Neoplasms/secondary , Mammary Neoplasms, Experimental/therapy , Adenocarcinoma/therapy , Adjuvants, Immunologic , Animals , Cimetidine/therapeutic use , Famotidine/therapeutic use , Female , Interleukin-2/therapeutic use , Killer Cells, Natural/immunology , Lung Neoplasms/therapy , Mammary Neoplasms, Experimental/immunology , Mice , Mice, Inbred C3H , Neoplasm Metastasis , Neoplasm Transplantation , Ranitidine/therapeutic use
19.
Int Arch Occup Environ Health ; 65(1 Suppl): S83-6, 1993.
Article in English | MEDLINE | ID: mdl-8406944

ABSTRACT

Hair samples from three groups of occupationally exposed subjects were analyzed for their lead (Pb), manganese (Mn) and mercury (Hg) contents. For lead (number of subjects, n = 209), the hair Pb ranged from 0.93 to 3527 micrograms/g (geometric mean, GM = 641) and blood Pb from 33.3 to 774 micrograms/l (GM = 341); for manganese (n = 38), the hair Mn ranged from 0.20 to 52.97 micrograms/g (GM = 2.66) and urine Mn ranged from 1.70 to 17.9 micrograms/l (GM = 5.56); and for mercury (n = 85), the hair Hg from 1.79 to 12.8 micrograms/g (GM = 5.09) and the blood Hg from 0.63 to 57.3 micrograms/l (GM = 10.9). The hair Pb was significantly (P < 0.0001) correlated to blood Pb (r = 0.85); the hair Mn to urinary Mn (r = 0.45); and the hair Hg to blood Hg (r = 0.53). The average metal content at the distal end was not significantly (P > 0.05) different from that of proximal end. The GM levels for the distal end were 223 micrograms/g (95% CI 152-347) and 2.26 (95% CI 0.97-5.29); and those for the proximal end were 186 (95% CI 97-261) and 1.18 (95% CI 0.54-2.58) for Pb and Mn respectively.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Environmental Monitoring/methods , Hair/chemistry , Lead/analysis , Manganese/analysis , Mercury/analysis , Humans , Lead/blood , Manganese/urine , Mercury/blood , Occupational Exposure/analysis , Regression Analysis
20.
Cancer Res ; 52(23): 6452-62, 1992 Dec 01.
Article in English | MEDLINE | ID: mdl-1423293

ABSTRACT

We examined: (a) whether in vitro-generated lymphocyte-activated killer (LAK) cells from normal mice and splenic killer cells from tumor-bearing mice subjected to interleukin-2 (IL-2) therapy alone or in combination with chronic indomethacin therapy have any detrimental effects on the spleen colony-forming units (CFU-S) of the normal bone marrow (BM); and (b) the effects of these immunotherapy protocols on CFU-S numbers in host hemopoietic organs. Effects of in vitro-generated LAK cells (normal C3H/HeN mouse splenocytes cultured with 1000 units IL-2/10(6) cells for 72 h) on BM CFU-S were examined by incubating macrophage-depleted BM cells with LAK cells at 1:2.5 and 1:5 BM:LAK cell ratios or with LAK cell supernatant for 4 h. The cells were washed and subsequently injected into irradiated mice. Irradiated mice were also reconstituted with BM cells or LAK cells incubated alone. Spleen colonies were scored macroscopically and microscopically on day 7 after reconstitution of lethally irradiated mice with the various cell combinations. A comparison of colony numbers produced by LAK and BM cell mixture revealed that LAK cells at either dose had no suppressive effect on the colony-forming ability of BM at the macroscopic and microscopic levels of analysis. The supernatant of cultured LAK cells had a minor suppressive effect on colony formation at the macroscopic but not the microscopic level of analysis, indicating the presence of one or more suppressive factors capable of mediating a short-term inhibitory effect. In the immunotherapy experiment, C3H/HeN mice transplanted s.c. with 5 x 10(5) C3L5 mammary adenocarcinoma cells received either vehicle alone (controls), IL-2 (1.5 x 10(4) Cetus units i.p. every 8 h on days 10-14 and days 20-25), or chronic indomethacin therapy (10 micrograms/ml in drinking water from day 5 onwards) plus IL-2 as above. Animals were killed 24-25 days after tumor transplantation to examine: (a) the number of metastatic lung nodules; (b) the effects of co-incubating therapy-generated splenic effector cells with normal BM cells for 4 h on BM CFU-S, and (c) the CFU-S content of host BM and spleen. Results revealed a drop in spontaneous lung metastases from a mean of 50 in control mice to 18 with IL-2 therapy alone, and to 5 with chronic indomethacin therapy plus IL-2 therapy. Splenocytes from normal and tumor-bearing control or treated mice, when incubated with normal BM, had no effect on spleen colony formation at the macroscopic level.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Hematopoietic Stem Cells/drug effects , Indomethacin/pharmacology , Interleukin-2/pharmacology , Killer Cells, Lymphokine-Activated/immunology , Tumor Stem Cell Assay , Animals , Cell Count , Female , Immunotherapy , Indomethacin/therapeutic use , Interleukin-2/therapeutic use , Lung Neoplasms/secondary , Mammary Neoplasms, Animal/immunology , Mammary Neoplasms, Animal/therapy , Mice , Mice, Inbred C3H , Neoplasm Transplantation , Phenotype , Spleen/immunology , Spleen/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...